Regenerative Medicine and Tissue Engineering

Regenerative medicine and tissues engineering are the branches of biomedical engineering. Tissue engineering and regenerative medicines are involved in the regeneration or replacement of cells, tissues or organs to revive traditional biological function. Tissue engineering could be an aggressive space of analysis that aims to make tissue equivalents of blood vessels, heart muscular tissue, nerves, cartilage, bone, and alternative organs for replacement of tissue either broken through sickness or trauma. As a knowledge domain field, principles from biological, chemical, electrical, materials science, and engineering are used in analysis and development.

The global Regenerative medicine market is estimated to reach USD 38.70 Billion by 2021 from USD 13.41 Billion at a CAGR of 23.6% from 2016 to 2021. The major factors that are raising the growth of this market are government and private funding in order to support the development of regenerative medicine, decrease the prevalence of chronic diseases and genetic disorders.